Response to comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
- Univ. of Wisconsin, Milwaukee, WI (United States)
- Univ. of North Carolina, Chapel Hill, NC (United States)
- Vanderbilt Univ., Nashville, TN (United States)
- Univ. of Tennessee, Knoxville, TN (United States)
- Univ. of Cincinnati, OH (United States)
Early in the SARS-CoV-2 pandemic, we compared transcriptome data from hospitalized COVID-19 patients and control patients without COVID-19. We found changes in procoagulant and fibrinolytic gene expression in the lungs of COVID-19 patients. These findings have been challenged based on issues with the samples. We have revisited our previous analyses in the light of this challenge and find that these new analyses support our original conclusions.
- Research Organization:
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE; Novo Nordisk; Bristol Myers Squibb; Bayer
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 1855666
- Journal Information:
- eLife, Journal Name: eLife Journal Issue: na Vol. 11; ISSN 2050-084X
- Publisher:
- eLife Sciences Publications, Ltd.Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung
Controlling the pandemic during the SARS-CoV-2 vaccination rollout
Singleplex, multiplex and pooled sample real-time RT-PCR assays for detection of SARS-CoV-2 in an occupational medicine setting
Journal Article
·
2021
· eLife
·
OSTI ID:1769526
+5 more
Controlling the pandemic during the SARS-CoV-2 vaccination rollout
Journal Article
·
2021
· Nature Communications
·
OSTI ID:1804438
+5 more
Singleplex, multiplex and pooled sample real-time RT-PCR assays for detection of SARS-CoV-2 in an occupational medicine setting
Journal Article
·
2022
· Scientific Reports
·
OSTI ID:1894387
+20 more